285 related articles for article (PubMed ID: 14708972)
1. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase.
Pollard PJ; Wortham NC; Tomlinson IP
Ann Med; 2003; 35(8):632-9. PubMed ID: 14708972
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
[TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
4. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the TCA cycle: signaling to tumor formation.
Raimundo N; Baysal BE; Shadel GS
Trends Mol Med; 2011 Nov; 17(11):641-9. PubMed ID: 21764377
[TBL] [Abstract][Full Text] [Related]
7. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM; Hornick JL; Bovée JVMG
Lab Invest; 2018 Apr; 98(4):414-426. PubMed ID: 29339836
[TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
9. A role for mitochondrial enzymes in inherited neoplasia and beyond.
Eng C; Kiuru M; Fernandez MJ; Aaltonen LA
Nat Rev Cancer; 2003 Mar; 3(3):193-202. PubMed ID: 12612654
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
11. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
12. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
[TBL] [Abstract][Full Text] [Related]
13. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
[TBL] [Abstract][Full Text] [Related]
15. On the association of succinate dehydrogenase mutations with hereditary paraganglioma.
Baysal BE
Trends Endocrinol Metab; 2003 Dec; 14(10):453-9. PubMed ID: 14643060
[TBL] [Abstract][Full Text] [Related]
16. The functional roles of TCA cycle metabolites in cancer.
Eniafe J; Jiang S
Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
[TBL] [Abstract][Full Text] [Related]
18. Differential metabolic consequences of fumarate hydratase and respiratory chain defects.
Raimundo N; Ahtinen J; Fumić K; Barić I; Remes AM; Renkonen R; Lapatto R; Suomalainen A
Biochim Biophys Acta; 2008 May; 1782(5):287-94. PubMed ID: 18313410
[TBL] [Abstract][Full Text] [Related]
19. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.
Evenepoel L; Papathomas TG; Krol N; Korpershoek E; de Krijger RR; Persu A; Dinjens WN
Genet Med; 2015 Aug; 17(8):610-20. PubMed ID: 25394176
[TBL] [Abstract][Full Text] [Related]
20. Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).
Jiménez-Morales S; Pérez-Amado CJ; Langley E; Hidalgo-Miranda A
Int J Oncol; 2018 Sep; 53(3):923-936. PubMed ID: 30015870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
